Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study

Journal of Infectious Diseases

Volumn 183, Issue 8, 2001, Pages 1290-1294

  Viard, Jean Paul ^a   Mocroft, Amanda ^b   Chiesi, Antonio ^d   Kirk, Ole ^e   Røge, Birgit ^f   Panos, George ^g   Vetter, Norbert ^h   Bruun, Johan N ⁱ   Johnson, Margaret ^c   Lundgren, Jens D ^e  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e HVIDOVRE HOSPITAL   (Denmark)

^f Rigshospitalet   (Denmark)

^g 1st IKA Hospital   (Greece)

^h Pulmologisches Zentrum   (Austria)

ⁱ ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL ANALYSIS; THYMUS FUNCTION; VIRUS LOAD;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE INHIBITORS; TIME FACTORS;

EID: 0035871818     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319678     Document Type: Article

References (16)

1. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection
2. Changes in thymic function with age and during the treatment of HIV infection
3. Thymus volume correlates with the progression of vertical HIV infection
4. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
5. Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients
6. 1993 Classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
7. CCR5 Δ32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients
8. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA study
9. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study
10. + T-cell counts
11. + T-lymphocyte regeneration after intensive chemotherapy
12. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
13. + T-cell pool during HIV-1 infection and combination antiretroviral therapy
14. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
15. Factors influencing T-cell turnover in HIV-1-seropositive patients
16. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients